Translating The Foreign Corrupt Practices Act Into Practice: U.S. DoJ/SEC Offer Pragmatic Enforcement Guide
This article was originally published in PharmAsia News
The FCPA resource guide gives examples of cases the DoJ and SEC have decided not to prosecute and describes the hallmarks of an effective compliance program; PhRMA, GPhA among groups that were asking for more clarity.
You may also be interested in...
BEIJING - It is a common refrain now for companies that do business in China that the country's intellectual property protection regime, while not perfect, is improving. But a recent conference on regulatory and legal issues in Beijing provided some discouraging examples about the challenges companies face in dealing with patent litigation and import certification in China
Johnson & Johnson agreed to pay $70 million to resolve charges by the Securities and Exchange Commission and the Department of Justice that the company bribed doctors in several European countries to order or prescribe its products in violation of the Foreign Corrupt Practices Act
Pitfalls of using third-party hubs for reimbursement assistance, sharing preapproval data with patient groups, and promoting biosimilars with labeling carveouts are among the concerns noted by panelists at FDLI conference.